Botulinum Neurotoxin (BoNT) therapeutics: Time to think outside the BoNT?

Botulinum Journal

Volumn 1, Issue 3, 2009, Pages 261-269

  Larsen, Joseph C ^a  

^a DEFENSE THREAT REDUCTION AGENCY   (United States)

Author keywords

BoNT; Botulinum neurotoxin; Host directed; Therapeutic

Indexed keywords

BOTULINUM ANTISERUM; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN E; BOTULINUM TOXIN INHIBITOR; RICIN; SHIGA TOXIN; SNARE PROTEIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTAXIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BOTULISM; CATALYSIS; CONFORMATIONAL TRANSITION; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG TARGETING; ENZYME STRUCTURE; ENZYME SUBSTRATE; HALF LIFE TIME; HUMAN; INTOXICATION; MOLECULAR DYNAMICS; NERVE CELL; NERVE CELL PLASTICITY; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NONHUMAN; PARALYSIS; PATHOGENESIS; PRESYNAPTIC NERVE; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; SEROTYPE; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 79551488865     PISSN: 17547326     EISSN: 17547318     Source Type: Journal    
DOI: 10.1504/TBJ.2009.031678     Document Type: Article

References (50)

1. Adler, M., Keller, J.E., Sheridan, R.E. and Deshpande, S.S. (2001) 'Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle', Toxicon, Vol. 39, pp.233-243. (Pubitemid 30649070)
2. Angaut-Petit, D., Molgo, J., Faille, L., Juzans, P. and Takahasi, M. (1998) 'Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned motor endings during enhanced quantal acetylcholine release', Brain Res., Vol. 797, pp.357-360. (Pubitemid 28332752)
3. Apland, J.P., Adler, M. and Oyler, G. (2003) 'Inhibition of neurotransmistter release by peptides that mimic the N-terminal domain of SNAP-25', J. Protein Chemistry, Vol. 22, pp.147-153. (Pubitemid 38115211)
4. Apland, J.P., Biser, J.A., Adler, M., Ferrer-Montiel, A.V., Montal, M., Canaves, J.M. and Filbert, M.G. (1999) 'Peptides that mimic the carboxyl-terminal domain of SNAP-25 block acetylcholine release at an Aplysia synapase', J. Appl. Toxicol., Vol. 19, Suppl., pp.S23-S26. (Pubitemid 30093515)
5. Arndt, J.W., Jacobson, M.J., Abola, E.E., Forsyth, C.M., Tepp, W.H., Marks, J.D., Johnson, E.A. and Stevens, R.C. (2006) 'A structural perspective of the sequence variability within botulinum neurotoxin subtypes A1-A4', J. Mol. Biol., Vol. 362, pp.733-742. (Pubitemid 44404084)
6. Bajohrs, M., Rickman, C., Binz, T. and Davletov, B. (2004) 'A molecular basis underlying differences in the toxicity of botulinum serotypes A and E', EMBO Reports, Vol. 5, pp.1090-1095. (Pubitemid 39600209)
7. Bianes-Mira, C., Ibanez, C., Fernandez-Ballester, G., Planells-Cases, R., Perez-Paya, E. and Ferrer-Montiel, A. (2001) 'Thermal stabilization of the catalytic domain of botulinum neurotoxin E by phosphorylation of a single tyrosine residue', Biochemistry, Vol. 40, pp.2234-2242. (Pubitemid 32165694)
8. Binz, T., Blasi, J., Yamasaki, S., Baumeister, A., Link, E., Sudhof, T.C., Jahn, R. and Niemann, H. (1994) 'Proteolysis of SNAP-25 by types E and A botulinal neurotoxins', J. Biol. Chem., Vol. 269, pp.1617-1620. (Pubitemid 24035350)
9. Breidenbach, M.A. and Brunger, A.T. (2004) 'Substrate recognition strategy for botulinum neurotoxin serotype A', Nature, Vol. 432, pp.925-929. (Pubitemid 40037157)
10. Brunger, A.T., Jin, R. and Breidenbach, M.A. (2008) 'Highly specific interactions between botulinum neurotoxins and synaptic vesicle proteins', Cell Mol. Life Sci., Vol. 65, pp.2296-2306.
11. Chen, S., Hall, C. and Barbieri, J.T. (2008) 'Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin', J. Biol. Chem., Vol. 283, pp.21153-21159.
12. Chen, S., Kim, J.J. and Barbieri, J.T. (2007) 'Mechanism of substrate recognition by botulinum neurotoxin serotype A', J. Biol. Chem., Vol. 282, pp.9621-9627. (Pubitemid 47104595)
13. Coffield, J.A. and Yan, X. (2009) 'Neuritogenic actions of botulinum neurotoxin A on cultured motor neurons', J. Pharmacol. Exp. Ther., Vol. 330, pp.352-358.
14. Comella, J.X., Molgo, J. and Faille, L. (1993) 'Sprouting of mammalian motor nerve terminals induced by the in vivo injection of botuinum type-D toxin and the functional recovery of paralysed neuromuscular junctions', Neurosci. Lett., Vol. 153, pp.61-64. (Pubitemid 23147037)
15. Darcy, K.J., Staras, K., Collinson, L.M. and Goda, Y. (2006) 'Constitutive sharing of recycling synaptic vesicles between presynaptic boutons', Nature Neuroscience, Vol. 9, pp.315-321. (Pubitemid 43290960)
16. de Paiva, A., Meunier, F.A., Molgo, J., Aoki, K.R. and Dolly, J.O. (1999) 'Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals', PNAS, Vol. 96, pp.3200-3205. (Pubitemid 29148868)
17. Dong, M., Ilu, H., Tepp, W.H., Johnson, E.A., Janz, R. and Chapman, E.R. (2008) 'Glycosylated SV2A and SV2B mediated the entry of boutlinum neurotoxin E into neurons', Mol. Biol. Cell, Vol. 19, pp.5226-5237.
18. Dong, M., Yeh, F., Tepp, W.H., Dean, C., Johnson, E.A., Janz, R. and Chapman, E.R. (2006) 'SV2 is the protein receptor for botulinum neurotoxin A', Science, Vol. 312, pp.592-596.
19. Encinar, J.A., Fernandez, A., Ferragut, J.A., Gonzalez-Ros, J.M., DasGupta, B.R., Montal, M. and Ferrer-Montiel, A. (1998) 'Structural stabilization of botulinum neurotoxin by tyrosine phosphorylation', FEBS Lett., Vol. 429, pp.78-82. (Pubitemid 28281249)
20. Eubanks, L.M., Hixon, M.S., Jin, W., Hong, S., Clancy, C.M., Tepp, W.H., Baldwin, M.R., Malizio, C.J., Goodnough, M.C., Barbieri, J.T., Johnson, E.A., Boger, D.L., Dickerson, T.J. and Janda, K.D. (2007) 'An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists', PNAS, Vol. 104, pp.2602-2607. (Pubitemid 46327926)
21. Fernandez-Salas, E., Steward, L.E., Ho, H., Garay, P.E., Sun, S.W., Gilmore, M.A., Ordas, J.V., Wang, J., Francis, J. and Aoki, K.R. (2004) 'Plasma membrane localization signals in the light chain of botulinum neurotoxin', PNAS, Vol. 101, pp.3208-3213. (Pubitemid 38327759)
22. Ferrer-Montiel, A.V., Canaves, J.M., DasGupta, B.R., Wilson, M.C. and Montal, M. (1996) 'Tyrosine phosphorylation modulates the activity of clostridial neurotoxins', J. Biol. Chem., Vol. 271, pp.18322-18325. (Pubitemid 26322682)
23. Ferrer-Montiel, A.V., Gutierrez, L.M., Apland, J.P., Canaves, J.M., Gil, A., Viniegra, S., Biser, J.A., Adler, M. and Montal, M. (1998) 'The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhbitis vesicle docking', FEBS Lett., Vol. 435, pp.84-88. (Pubitemid 28432020)
24. Foran, P.G., Mohammed, N., Lisk, G.O., Nagwaney, S., Lawrence, G.W., Johnson, E., Smith, L., Aoki, K.R. and Dolly, J.O. (2003) 'Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons', J. Biol. Chem., Vol. 278, pp.1363-1371. (Pubitemid 36790822)
25. Ibanez, C., Blanes-Mira, C., Fernandez-Ballester, G., Planells-Cases, R. and Ferrer-and Montiel, A. (2004) 'Modulation of botulinum neurotoxin A catalytic domain stability by tyrosine phosphorylation', FEBS Lett., Vol. 578, pp.121-127. (Pubitemid 39576112)
26. Jandhyala, D.M., Ahluwalia, A., Obrig, T. and Thorpe, C.M. (2008) 'ZAK: A MAP3Kinase that transduces Shiga toxin-and ricin-induced proinflammatory cytokine expression', Cell Microbiol., Vol. 10, pp.1468-1477. (Pubitemid 351837267)
27. Jurasinski, C.V., Lieth, E., Dang Do, A.N. and Schengrund, C-L. (2001) 'Correlation of cleavage of SNAP-25 with muscles function in a rat model of Botulinum neurotoxin type A induced paralysis', Toxicon, Vol. 39, pp.1309-1315. (Pubitemid 32510960)
28. Juzans, P., Comella, J.X., Molgo, J., Faille, L. and Angaut-Petit, D. (1996) 'Nerve terminal sprouting in botulinum type-A treated mouse levator auris longus muscle', Neuromuscul. Disord., Vol. 6, pp.177-185. (Pubitemid 26171260)
29. Keller, J.E. and Neale, E.A. (2001) 'The role of synaptic protein SNAP-25 in the potency of botulinum neurotoxin type A', J. Biol. Chem., Vol. 276, pp.13476-13482.
30. Keller, J.E., Neale, E.A., Oyler, G. and Adler, M. (1999) 'Persistence of botulinum neurotoxin action in cultured spinal cord cells', FEBS Lett., Vol. 456, pp.137-142. (Pubitemid 29339056)
31. Kessler, K.R. and Benecke, R. (1997) 'Botulinum toxin: from poison to remedy', Neurotoxicology, Vol. 18, pp.761-770. (Pubitemid 27430304)
32. Kongsaengdao, S., Samintarapanya, K., Rusmeechan, S., Wongsa, A., Pothirat, C., Permpikul, C., Pongpakdee, S., Puavilai, W., Kateruttanakul, P., Phengtham, U., Panjapornpon, K., Janma, J., Piyavechviratana, K., Sithinamsuwan, P., Deesomchok, A., Tongyoo, S., Vilaichone, W., Boonyapisit, K., Mayotarn, S., Piya-Isragul, B., Rattanaphon, A., Intalapaporn, P., Dusitanond, P., Harnsomburana, P., Laowittawas, W., Chairangsaris, P., Suwantamee, J., Wongmek, W., Ratanarat, R., Poompichate, A., Panyadilok, H., Sutcharitchan, N., Chuesuwan, A., Oranrigsupau, P., Sutthapas, C., Tanprawate, S., Lorsuwansiri, J. and Phattana, N. (for the Thai Botulism Study Group) (2006) 'An outbreak of botulism in Thailand: clinical manifestations and management of severe respiratory failure', Clin. Infect. Dis., Vol. 43, pp.1247-1256. (Pubitemid 44706449)
33. Kumaran, D., Eswaramoorthy, S., Furey, W., Navaza, J., Sax, M. and Swaminathan, S. (2009) 'Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation', J. Mol. Biol., Vol. 386, pp.233-2454.
34. Kumaran, D., Rawat, R., Ahmed, S.A. and Swaminathan, S. (2008) 'Substrate binding mode and its implication on drug design for botulinum neurotoxin A', PLoS Pathog, Vol. 4, p.e1000165.
35. Lane, S.R. and Liu, Y. (1997) 'Characterization of the palmitoylation domain of SNAP-25', J. Neurochem., Vol. 69, pp.1864-1869. (Pubitemid 27452731)
36. Meunier, F.A., Giampietro, S. and Molgo, J. (2002) 'Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission', Journal of Physiol., Vol. 96, pp.105-113. (Pubitemid 34087038)
37. Meunier, F.A., Lisk, G., Sesardic, D. and Dolly, J.O. (2003) 'Dynamics of motor nerve terminal remodeling unveiled using SANRE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation', Mol Cell Neurosci., Vol. 22, pp.454-466. (Pubitemid 36513569)
38. Millard, C. (2006) 'Medical defense against toxin weapons: review and perspective', in Lindler, L.E., Lebeda, F.J. and Korch, G.W. (Eds.): Infectious Disease: Biological Weapons Defense: Infectious Diseases and Counterterrorism, Humana Press Inc., Totowa, NJ, pp.255-283.
39. Montecucco, C. and Schiavo, G. (1995) 'Structure and function of tetanus and botulinum neurotoxins', Q. Rev. Biophys., Vol. 28, pp.423-472. (Pubitemid 26015975)
40. Oyler, G., Kincaid, R., Tziport, S. and Shoemaker, C.B. (2006) 'Progress towards understanding the cellular biology and treatment of BoNT LC perisistence', Platform Presentation 43rd Interagency Botulism Research Coordinating Committee Meeting, 14-17 November, Silver Spring, MD.
41. Oyler, G.A., Tsai, Y.C., Silvaggi, N.R., Allend, K.N., Tzipori, S. and Shoemaker, C.B. (2008) 'Therapeutics which inhibit BoNT/A LC function and accelerate degradation within neurons', Platform Presentation 45th Interagency Botulism Research Coordinating Committee Meeting, 14-18 September, Philadelphia, PA.
42. Poulain, B., Popoff, M.R. and Molgo, J. (2008) 'How do the botulinum neurotoxins block neurotransmitter release: from botulism to the molecular mechanism of action', The Botulinum J., Vol. 1, pp.14-89.
43. Ravichandran, E., Gong, Y., Al Saleem, F.H., Ancharski, D.M., Joshi, S.G. and Simpson, L.L. (2006) 'An initial assessment of the systemic pharmacokinetics of botulinum toxin', J. Pharmacol. Exp. Ther., Vol. 318, pp.1343-1351. (Pubitemid 44268344)
44. Rogozhin, A.A., Pang, K.K., Bukharaeva, E., Young, C. and Slater, C.R. (2008) 'Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A', J. Physiol., Vol. 586, pp.3163-3182. (Pubitemid 351984697)
45. Schiavo, G., Santucci, A., Dasgupta, B.R., Mehta, P.P., Jontes, J., Benfenati, F., Wilson, M.C. and Montecucco, C. (1993) 'Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds', FEBS Lett., Vol. 335, pp.99-103. (Pubitemid 23347745)
46. Sikorra, S., Henke, T., Galli, T. and Binz, T. (2008) 'Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins', J. Biol. Chem., Vol. 283, pp.21145-21152.
47. Silvaggi, N.R., Boldt, G.E., Hixon, M.S., Kennedy, J.P., Tzipori, S., Janda, K.D. and Allen, K.N. (2007) 'Structures of Clostridium botulinum neurotoxin serotype A light chain complexed with small-molecule inhibitors highlight active-site flexibility', Chem. Biol., Vol. 14, pp.533-542. (Pubitemid 46765150)
48. Silvaggi, N.R., Wilson, D., Tzipori, S. and Allen, K.N. (2008) 'Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex', Biochemistry, Vol. 47, pp.5736-5745. (Pubitemid 351747052)
49. Zakharenko, S.S., Zablow, L. and Siegelbaum, S.A. (2001) 'Visulaization of changes in presynaptic function during long-term synaptic plasticity', Nat. Neurosci., Vol. 4, pp.711-717. (Pubitemid 32595409)
50. Zuniga, J.E., Schmidt, J.J., Fenn, T., Burnett, J.C., Arac, D., Gussio, R., Stafford, R.G., Badie, S.S., Bavari, S. and Brunger, A.T. (2008) 'A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a different conformation than SNAP-25 substrate', Structure, Vol. 16, pp.1588-1597.